202 related articles for article (PubMed ID: 29474777)
1. IVABRADINE LOADED SOLID LIPID MICROPARTICLES: FORMULATION, CHARACTERIZATION AND OPTIMIZATION BY CENTRAL COMPOSITE ROTATABLE DESIGN.
Hanif M; Khan HU; Afzal S; Sher M
Acta Pol Pharm; 2017 Jan; 74(1):211-226. PubMed ID: 29474777
[TBL] [Abstract][Full Text] [Related]
2. Sustained release biodegradable solid lipid microparticles: Formulation, evaluation and statistical optimization by response surface methodology.
Hanif M; Khan HU; Afzal S; Mahmood A; Maheen S; Afzal K; Iqbal N; Andleeb M; Abbas N
Acta Pharm; 2017 Dec; 67(4):441-461. PubMed ID: 29337670
[TBL] [Abstract][Full Text] [Related]
3. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
[TBL] [Abstract][Full Text] [Related]
4. Determination of solid state characteristics of spray-congealed Ibuprofen solid lipid microparticles and their impact on sustaining drug release.
Wong PC; Heng PW; Chan LW
Mol Pharm; 2015 May; 12(5):1592-604. PubMed ID: 25849584
[TBL] [Abstract][Full Text] [Related]
5. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
6. Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids.
Chinaeke EE; Chime SA; Onyishi VI; Attama AA; Okore VC
Drug Deliv; 2015; 22(5):652-65. PubMed ID: 24479677
[TBL] [Abstract][Full Text] [Related]
7. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid microparticles as a sustained release system for pulmonary drug delivery.
Jaspart S; Bertholet P; Piel G; Dogné JM; Delattre L; Evrard B
Eur J Pharm Biopharm; 2007 Jan; 65(1):47-56. PubMed ID: 16962749
[TBL] [Abstract][Full Text] [Related]
9. Entrapment and release kinetics of furosemide from pegylated nanocarriers.
Youm I; Murowchick JB; Youan BB
Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795
[TBL] [Abstract][Full Text] [Related]
10. FORMULATION AND IN VITRO EVALUATION OF ACYCLOVIR LOADED POLYMERIC MICROPARTICLES: A SOLUBILITY ENHANCEMENT STUDY.
Mahmood A; Ahmad M; Sarfraz RM; Minhas MU; Yaqoob A
Acta Pol Pharm; 2016 Sep; 73(5):1311-1324. PubMed ID: 29638071
[TBL] [Abstract][Full Text] [Related]
11. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.
Gurumukhi VC; Bari SB
Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
Momoh MA; Kenechukwu FC; Attama AA
Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
[TBL] [Abstract][Full Text] [Related]
13. Quality-by-design approach for development of sustained-release multiple-unit beads of lamotrigine based on ion-cross-linked composite of pectin and okra mucilage: An in vitro appraisal.
Das S; Ghosh A; Changder A; Nandi G; Ghosh LK
Int J Biol Macromol; 2020 Nov; 163():842-853. PubMed ID: 32653379
[TBL] [Abstract][Full Text] [Related]
14. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
[TBL] [Abstract][Full Text] [Related]
15. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
16. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
17. Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine.
Agnihotri SA; Aminabhavi TM
Int J Pharm; 2006 Nov; 324(2):103-15. PubMed ID: 16824710
[TBL] [Abstract][Full Text] [Related]
18. A study on the solid state characteristics of spray-congealed glyceryl dibehenate solid lipid microparticles containing ibuprofen.
Wong PC; Heng PW; Chan LW
Drug Dev Ind Pharm; 2016; 42(3):364-77. PubMed ID: 26079425
[TBL] [Abstract][Full Text] [Related]
19. Production and structural characterization of solid lipid microparticles loaded with soybean protein hydrolysate.
Salvim MO; Thomazini M; Pelaquim FP; Urbano A; Moraes ICF; Favaro-Trindade CS
Food Res Int; 2015 Oct; 76(Pt 3):689-696. PubMed ID: 28455054
[TBL] [Abstract][Full Text] [Related]
20. Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices from Moringa oleifera.
Onyishi IV; Chime SA; Ogudiegwu EO
Pharm Dev Technol; 2015; 20(5):546-54. PubMed ID: 24964095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
